Alerts will be sent to your verified email
Verify EmailSANDUPHQ
|
Sandu Pharmaceutical
|
Bandaram Pharma Pack
|
Goldline Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.72 % | 5.64 % | 18.23 % |
|
5yr average Equity Multiplier
|
1.33 | 4.09 | 2.92 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 0.98 | 1.04 |
|
5yr Avg Net Profit Margin
|
2.27 % | 1.46 % | 6.35 % |
|
Price to Book
|
0.93 | 1.46 | 0.0 |
|
P/E
|
25.22 | 87.81 | 9.05 |
|
5yr Avg Cash Conversion Cycle
|
48.49 Days | 185.52 Days | 160.68 Days |
|
Inventory Days
|
74.6 Days | 58.64 Days | 97.06 Days |
|
Days Receivable
|
26.14 Days | 164.3 Days | 132.15 Days |
|
Days Payable
|
72.73 Days | 29.07 Days | 67.16 Days |
|
5yr Average Interest Coverage Ratio
|
28.2 | 2.12 | 2.27 |
|
5yr Avg ROCE
|
5.33 % | 8.53 % | 30.67 % |
|
5yr Avg Operating Profit Margin
|
3.77 % | 7.35 % | 16.99 % |
|
5 yr average Debt to Equity
|
0.0 | 2.33 | 1.44 |
|
5yr CAGR Net Profit
|
0.39 % | 16.17 % | 61.2 % |
|
5yr Average Return on Assets
|
2.79 % | 1.43 % | 6.66 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.79 % | 62.66 % | 57.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.62 % | -12.34 % | 57.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sandu Pharmaceutical
|
Bandaram Pharma Pack
|
Goldline Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|